Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEETINGS - In3 Medical Device Summit (US) June 2006:

This article was originally published in Clinica

Executive Summary

In3 Medical Device Summit will be hosted by Medtech Insight during June 21-23 2006 at The Palace Hotel, California, San Francisco, US. Dedicated to previewing cutting-edge emerging medtech companies, presentations will be in three categories: cardio and peripheral vascular diagnostics/therapeutics; ortho and spine; and other innovative technologies. Among the conference topics are: market analysis of where medtech companies are going and launching/financing a start-up. For information and to register, contact Kristy Grimes, on tel: +1 480 985 9512; email: kristy@medtechinsight.com www.meddevicesummit.com/content/Main.aspx

You may also be interested in...



Perrigo Oral Care Targets North American Value Tier With High Ridge Brands Acquisition

REACH and Dr. Fresh, as well as Firefly kids’ toothbrushes and mouth rinses featuring popular comic book and cartoon characters, will join Perrigo’s Ranir division under the $113m cash deal, which is subject to federal bankruptcy court approval but expected to close in the 2020 first quarter.

Sold! Tengram Leaves High Ridge Auction With Iconic Brands Including Zest, Alberto VO5

Subject to the approval of a federal bankruptcy court presiding over High Ridge Brands’ Chapter 11 case, private equity firm Tengram will add a raft of personal cleansing and hair-care brands to its portfolio while bringing back former High Ridge CEO James Daniels to head up the collection’s rejuvenation.

Top FDA Officials: Agency Actively Cracking Down On Medical Products With Sham COVID-19 Claims

US FDA commissioner Stephen Hahn and ORA associate commissioner for regulatory affairs Judith McMeekin said in a joint 24 February statement that the agency continues to aggressively monitor the market for any firms selling products with fraudulent COVID-19 prevention and treatment claims. The officials also explained that the FDA has the authority under FDASIA to ask for records from drug manufacturers in lieu of conducting facility inspections. It can't do the same for device companies, however, because no similar provision exists. The FDA had announced on 14 February that it paused all inspections of Chinese manufacturing facilities in the near-term.

Topics

UsernamePublicRestriction

Register

MT051840

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel